weekly glp 1 drugs GLP-1 Drug Comparison in Diabetes and Obesity Treatment Understanding GLP Drugs: What They

Mcilwain CC, Townsend DM, Tew KD

Doseresponse effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP- 1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial

Canada Europe Germany France UK Italy Spain Netherlands Russia Rest of Europe Asia Pacific China Japan India Malaysia South Korea Indonesia Australia Vietnam Rest of Asia Pacific Middle East & Africa Saudi Arabia UAE Israel South Africa Rest of Middle East & Africa Latin America Mexico Brazil Argentina Rest of Latin America GLP-1 Market Report Scope Source: Polaris Market Research Analysis GLP-1 Market FAQ's The GLP-1 market was valued at USD 52.82 billion in 2025 and is projected to reach USD 133.92 billion by 2034

Holding the bottle in your hand for 1-2 minutes before dosing takes the edge off the cold without compromising stability